How is the company looking from a Valuation perspective?
FY23 Q3 numbers seem okay, with flat revenues but a rise in PAT and Market share. Currently, the company is trading at a P/E of 13 with a median of the last 2 years of 21, Market Cap/Sales of 3.9 with a median of 5. As the company got listed during the quantitative easing time, it won’t be reasonable to compare the ratios.
Can anyone guide/comment upon this?
| Subscribe To Our Free Newsletter |
